Get started
Author

Fabian P. M. Reich

Efficacy of docetaxel plus ramucirumab as palliative second-line therapy following first-line chemotherapy plus immune-checkpoint-inhibitor combination treatment in patients with non-small cell lung cancer (NSCLC) UICC stage IV
2021 · Wolfgang M. Brueckl, Martin Reck, et al. · Translational Lung Cancer Research · 33
PDF
Efficacy of Docetaxel Plus Ramucirumab as Palliative Third-Line Therapy Following Second-Line Immune-Checkpoint-Inhibitor Treatment in Patients With Non-Small-Cell Lung Cancer Stage IV
2020 · Wolfgang M Brueckl, Martin Reck, et al. · Clinical Medicine Insights Oncology · 32
PDF
3-Deazaadenosine Prevents Smooth Muscle Cell Proliferation and Neointima Formation by Interfering With Ras Signaling
2009 · Daniel G. Sedding, Monique Tröbs, et al. · Circulation Research · 25
PDF
Predictive value of mRNA expression and dynamic changes from immune related biomarkers in liquid biopsies before and after start of pembrolizumab in stage IV non-small cell lung cancer (NSCLC)
2021 · Natalie F. Brueckl, Ralph M. Wirtz, et al. · Translational Lung Cancer Research · 7
PDF
Cleaved high-molecular-weight kininogen inhibits neointima formation following vascular injury
2015 · Jan-Marcus Daniel, Fabian Reich, et al. · Thrombosis and Haemostasis · 7
Fluctuation of Acquired Resistance Mutations and Re-Challenge with EGFR TKI in Metastatic NSCLC: A Case Report
2023 · Markus Falk, Stefanie Schatz, et al. · Current Oncology · 4
PDF
Abstract 605: High Molecular Weight Kininogen Prevents Vascular Smooth Muscle Progenitor Cell Accumulation to Sites of Vascular Injury and Prevents Neointima Formation
2007 · Daniel Sedding, Fabian Reich, et al. · Circulation · 1
Works count: 8
Citation count: 109
H-index: 5
I10-index: 3
Year
Topic
Type